(Q46899634)

English

Oral, more than transdermal, oestrogen therapy lowers asymmetric dimethylarginine in healthy postmenopausal women: a randomized, placebo-controlled study

scientific article published in February 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420549

Oral, more than transdermal, oestrogen therapy lowers asymmetric dimethylarginine in healthy postmenopausal women: a randomized, placebo-controlled study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420549

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Verhoeven MO

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420549

Hemelaar M

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420549

van der Mooren MJ

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420549

Kenemans P

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420549

Teerlink T

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420549

language of work or name

0 references

publication date

1 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420549

Journal of Internal Medicine

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420549

259

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420549

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420549

199-208

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420549

Cardiovascular health and disease in women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Estrogen plus progestin and the risk of coronary heart disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

A randomized placebo-controlled study of the effect of transdermal vs. oral estradiol with or without gestodene on homocysteine levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Effects of oral and transdermal low-dose estrogen therapy on echocardiographic parameters of cardiac function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: a randomized placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Effects of transdermal and oral postmenopausal hormone therapy on vascular function: a randomized, placebo-controlled study in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Endogenous Dimethylarginine as an Inhibitor of Nitric Oxide Synthesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Effect of endogenous estrogen on endothelial function in women with coronary heart disease and its mechanism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Effect of hormone replacement therapy on plasma levels of the cardiovascular risk factor asymmetric dimethylarginine: a randomized, placebo-controlled 12-week study in healthy early postmenopausal women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Estrogenic effects of the synthetic aminoestrogen 17 beta-(5-hydroxy-1-pentylamino)-1,3,5(10)-estratrien-3-ol (pentolame).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Rat uterine complement C3 expression as a model for progesterone receptor modulators: characterization of the new progestin trimegestone

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

17beta-estradiol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Asymmetric dimethylarginine and total homocysteine in plasma after oral methionine loading

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

The transplanted liver graft is capable of clearing asymmetric dimethylarginine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Lifetime risk of developing coronary heart disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01602.X

21 January 2018

Identifiers

10.1111/J.1365-2796.2005.01602.X

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420549

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16420549

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46899634&oldid=2136995285"